Clinical trial
Amikacin Penetration Into the Cerebrospinal Fluid
NCT00362245 · Rambam Health Care Campus, Other · Withdrawn
Key facts
| NCT number | NCT00362245 |
|---|---|
| Title | Amikacin Penetration Into the Cerebrospinal Fluid |
| Official title | Amikacin Penetration Into the Cerebrospinal Fluid: Pharmacokinetic/Pharmacodynamic Analysis in Adults With Hospital Acquired Gram-negative Meningitis Associated With Intracranial Pressure Monitoring and Draining Devices |
| Lead sponsor | Rambam Health Care Campus, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gram Negative Meningitis, Post Traumatic Bacterial Meningitis |
| Intervention type | Drug |
| Interventions | Systemic and Intra-Thecal Amikacin Therapy |
| Enrollment | 0 |
| Start date | Sep 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Aug 9, 2006 |
| Last update posted | Nov 3, 2015 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: